JNJ vs BSX
By Alex · Tickerpine
Johnson & Johnson vs Boston Scientific Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BSX |
|---|---|---|
| Price | $273.14 | $49.86 |
| Market cap | $658.24B | $72.26B |
| P/E ratio | 31.7 | 20.2 |
| ROE | 25.74% | 15.34% |
| Profit margin | 21.48% | 17.50% |
| Revenue growth | 6.60% | 7.50% |
| Dividend yield | 1.96% | — |
| Beta | 0.23 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BSX in plain English
- JNJ is the bigger company — about 9.1× the market cap of BSX.
- BSX is cheaper on earnings (P/E 20.2 vs 31.7).
- JNJ earns a higher return on equity (26% vs 15%).
- BSX is growing revenue faster (8% vs 7%).
- JNJ pays a dividend (1.96%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BSX return calculator
See what $1,000 in Boston Scientific Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.